Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Boehringer Ingelheim
Express Scripts
Medtronic
Colorcon

Last Updated: January 19, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Iodophenyl


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Iodophenyl?

Iodophenyl is an investigational drug.

There have been 9 clinical trials for Iodophenyl. The most recent clinical trial was a Phase 2 trial, which was initiated on August 7th 2017.

The most common disease conditions in clinical trials are Parkinson Disease, Neoplasms, Plasma Cell, and Colorectal Neoplasms. The leading clinical trial sponsors are Cellectar Biosciences, Inc., National Cancer Institute (NCI), and Pfizer.

There are two hundred and forty-one US patents protecting this investigational drug and fourteen international patents.

Recent Clinical Trials for Iodophenyl
TitleSponsorPhase
Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by SurgeryNational Cancer Institute (NCI)Phase 1
Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by SurgeryCity of Hope Medical CenterPhase 1
Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?Neurobiology Research Unit, Rigshospitalet, CopenhagenPhase 2

See all Iodophenyl clinical trials

Clinical Trial Summary for Iodophenyl

Top disease conditions for Iodophenyl
Top clinical trial sponsors for Iodophenyl

See all Iodophenyl clinical trials

US Patents for Iodophenyl

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Iodophenyl ⤷  Try it Free Antidiabetic tricyclic compounds Merck Sharp & Dohme (Rahway, NJ) ⤷  Try it Free
Iodophenyl ⤷  Try it Free Small molecules for the modulation of MCL-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders Dana-Farber Cancer Institute, Inc. (Boston, MA) ⤷  Try it Free
Iodophenyl ⤷  Try it Free Method of modulating stress-activated protein kinase system INTERMUNE, INC. (Brisbane, CA) ⤷  Try it Free
Iodophenyl ⤷  Try it Free Bridged bicyclic nucleosides MIRAGEN THERAPEUTICS, INC. (Boulder, CO) ⤷  Try it Free
Iodophenyl ⤷  Try it Free Substituted pyrrolidines as G-protein coupled receptor 43 agonists Ogeda SA (Gosselies, BE) ⤷  Try it Free
Iodophenyl ⤷  Try it Free Compounds and uses thereof for the modulation of hemoglobin Global Blood Therapeutics, Inc. (South San Francisco, CA) ⤷  Try it Free
Iodophenyl ⤷  Try it Free Branched 3-phenylpropionic acid derivatives and their use BAYER PHARMA AKTIENGESELLSCHAFT (Monheim, DE) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Iodophenyl

Drugname Country Document Number Estimated Expiration Related US Patent
Iodophenyl Australia AU2015263620 2034-05-22 ⤷  Try it Free
Iodophenyl Canada CA2947781 2034-05-22 ⤷  Try it Free
Iodophenyl China CN106458913 2034-05-22 ⤷  Try it Free
Iodophenyl European Patent Office EP3145915 2034-05-22 ⤷  Try it Free
Iodophenyl Japan JP2017516771 2034-05-22 ⤷  Try it Free
Iodophenyl South Korea KR20170005861 2034-05-22 ⤷  Try it Free
Iodophenyl Mexico MX2016015182 2034-05-22 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Boehringer Ingelheim
Express Scripts
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.